Accumed Pharmaceuticals Llp - Due diligence report
A 360° intelligence report on Accumed Pharmaceuticals Llp: trust score, financial health, credit view, compliance, directors, growth and dis…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Accumed Pharmaceuticals Llp — 360° Intelligence Report
Generated from MCA filings & public recordsAccumed Pharmaceuticals Llp is assessed as Moderate with a Trust Score of 68/100. Accumed Pharmaceuticals Llp is a limited liability partnership incorporated in 2014, operating in the Chemicals sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and an unassessed financial risk profile.
Report generated on 11 Oct 2026 from the latest processed filings. Accumed Pharmaceuticals Llp snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
No processed financialsCredit & Compliance Intelligence
Why the scores are what they are- Financial statements needed for a credit view.
Charges position: 0 open (-) · 0 satisfied (-).
- Company status is "Strike Off" - not Active.
- No balance-sheet filing date on record.
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ASHWIN PRAKASH KESHWANI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| USHA KESHWANI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth N/A · Distress 65Stakeholder Verdicts
Vendor · Banker · Investor- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- No financials on record - ask for audited statements.
- No filed financials - rely on banking statements and GST data.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
- No clear growth signals in the filed years.
- Request management accounts - public filings insufficient.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 3 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| ARIZONAL LLP | AAP-8567 | - |
| Kestrel Infrastructure Private Limited | U70100MH2005PTC154889 | - |
| Jewel Builders And Infraprojects Limited | U45202MH2011PLC211710 | - |
| Yash Integrated Solutions Private Limited | U67120MH2005PTC153405 | - |
| Eagle Plastochem Distributors Private Li Mited | U24117MH2005PTC157821 | - |
| Laxmi Infoway Private Limited | U72900MH2000PTC130229 | - |
| Konark Enviro Project Private Limited | U74900MH2013PTC249233 | - |
| 5TECH SYSTEMS LIMITED LIABILITY PARTNERS | AAB-7679 | - |
| Mahek Automation Private Limited | U29268MH2011PTC215837 | - |
| PROFOUND LIVING LLP | AAN-9925 | - |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Accumed Pharmaceuticals Llp before audits and certifications: compliance score 45/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Accumed Pharmaceuticals Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Accumed Pharmaceuticals Llp - screening before a deeper diligence.
Vendor verdict: Review suggested. Trust score 68/100, distress signals and MSME payment-delay disclosures - know whether Accumed Pharmaceuticals Llp pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Accumed Pharmaceuticals Llp - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Accumed Pharmaceuticals Llp an active company?
Accumed Pharmaceuticals Llp has MCA status “Strike Off” with a compliance score of 45/100 (Caution Indicated).
Is Accumed Pharmaceuticals Llp financially healthy?
Processed financial statements are not yet available for Accumed Pharmaceuticals Llp, so its financial health is unassessed.
Should I do business with Accumed Pharmaceuticals Llp?
Its overall Trust Score is 68/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Accumed Pharmaceuticals Llp?
See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.
Does Accumed Pharmaceuticals Llp have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Accumed Pharmaceuticals Llp up to date with its ROC filings?
No balance-sheet filing date on record. Overall compliance score: 45/100 (Caution Indicated).
Is it risky to lend to Accumed Pharmaceuticals Llp?
Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.